Intrinsiqs

Is Eledon Pharmaceuticals, Inc. overvalued?

Eledon Pharmaceuticals, Inc. (ELDN) — key valuation metrics and fundamentals.

No verdict
Price
$3.54
Fair value
Current P/E
Normal P/E
Market cap
$273.2M
Dividend yield
0.0%
Return on equity
-96.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ELDN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.